Technical Analysis for KHTRF - Knight Therapeutics

Grade Last Price % Change Price Change
grade C 5.594 0.43% 0.0240
KHTRF closed up 0.43 percent on Friday, October 11, 2019, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KHTRF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Ended Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 0.43%
Narrow Range Bar Range Contraction 0.43%
Oversold Stochastic Weakness 0.43%
Bollinger Band Squeeze Range Contraction 0.43%
Narrow Range Bar Range Contraction 0.43%
Gapped Down Weakness 0.43%

Older signals for KHTRF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally. The company is involved in developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. Its commercialized products include Movantik to treat opioid induced constipation; Impavido, an alkyllysophospholipid analogue drug for visceral and cutaneous Leishmaniasis; Neuragen to treat pain associated with diabetic and peripheral neuropathy; Synergy family consumer health products; and Flat Tummy Tea, a herbal detox tea. The company also develops Probuphine to treat opioid addiction; NeurAxon family for acute migraine, pain, and neurological disorders; Antibe family to treat chronic pain and inflammation; AzaSite for bacterial conjunctivitis; Iluvien to treat diabetic macular edema; Netildex for ocular inflammation; 60P family to treat tropical diseases; Advaxis family to treat HPV-associated cancers and others; PHOTOFRIN for oesophageal and endobronchial cancer, high-grade dysplasia in Barrett's oesophagus, and papillary bladder cancer; ATryn to prevent thromboembolic events; Ember family to treat osteoarthritis, chronic kidney diseases, alport syndrome, and metabolic diseases; and blood factor products. In addition, it develops FLEXISEQ for pain and joint stiffness associated with osteoarthritis; dermo-cosmetic line of products, such as Crescita family, Laboratoire Dr. Renaud, Premiology, and Pro-Derm; SEQuaderma, an active dermatology solution; HandMD skin care products; and UrgentRx, a fast-acting, portable over-the-counter medication. Further, the company develops TULSA-PRO, a medical device for prostate ablation; and 3D family diagnostic and prognostic products for cancers and neurological disorders. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company is headquartered in Montreal, Canada.
Medicine Health RTT Medical Specialties Pharmaceutical Pain Pharmaceutical Products Cancers Skin Care Products Arthritis Inflammation Osteoarthritis Pain Management Metabolic Diseases Chronic Pain Neurological Disorders Opioid Constipation Aging Associated Diseases Chronic Kidney Diseases Diabetic Macular Edema Consumer Health Products Peripheral Neuropathy Skeletal Disorders Syndrome
Is KHTRF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 8.0291
52 Week Low 5.3
Average Volume 3,243
200-Day Moving Average 6.078
50-Day Moving Average 5.6458
20-Day Moving Average 5.6897
10-Day Moving Average 5.6479
Average True Range 0.0674
ADX 10.84
+DI 40.0339
-DI 52.4875
Chandelier Exit (Long, 3 ATRs ) 5.6844
Chandelier Exit (Short, 3 ATRs ) 5.7722
Upper Bollinger Band 5.8584
Lower Bollinger Band 5.521
Percent B (%b) 0.22
BandWidth 5.930014
MACD Line -0.0307
MACD Signal Line -0.0127
MACD Histogram -0.018
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.5940
Resistance 3 (R3) 5.5940 5.5940 5.5940
Resistance 2 (R2) 5.5940 5.5940 5.5940 5.5940
Resistance 1 (R1) 5.5940 5.5940 5.5940 5.5940 5.5940
Pivot Point 5.5940 5.5940 5.5940 5.5940 5.5940
Support 1 (S1) 5.5940 5.5940 5.5940 5.5940 5.5940
Support 2 (S2) 5.5940 5.5940 5.5940 5.5940
Support 3 (S3) 5.5940 5.5940 5.5940
Support 4 (S4) 5.5940